The test examines your GLP1R rs6923761 variant and 49 other peptide-pathway genes to estimate how strongly your body's receptors will respond to semaglutide
[DOI] [PMC free article] [PubMed] [Google Scholar] 103.Nagata J.M., Garber A.K., Tabler J.L., Murray S.B., Bibbins-Domingo K
Some medical conditions and medications may limit its use
Nutrition optimization High protein intake (1.6g per lb of body weight) Vitamin C (collagen synthesis) Zinc and magnesium (growth factor signaling) Omega-3 fatty acids (inflammation management) 3
MedicalDaily will track new research on this topic as it is published and will report on any FDA label changes or official safety communications related to foot health in GLP-1 users
At the same time, the effect on weight management is also very prominent, especially for obese patients, which can significantly reduce their weight